MedAvail Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017 - 2010
Net Income	-47.62	-43.82	-26.81	-21.53	-3.22	Upgrade
Depreciation & Amortization	4.66	2.58	1.81	1.64	0.43	Upgrade
Share-Based Compensation	2.3	1.21	0.38	0.35	0.24	Upgrade
Other Operating Activities	-7	-2.49	-4.01	-0.01	-0.69	Upgrade
Operating Cash Flow	-47.66	-42.52	-28.63	-19.55	-3.25	Upgrade
Capital Expenditures	-2.3	-3.29	-0.66	-0.4	0	Upgrade
Other Investing Activities	0.03	-0.03	-0.16	-	-	Upgrade
Investing Cash Flow	-2.27	-3.31	-0.82	-0.4	0	Upgrade
Share Issuance / Repurchase	47.07	0.62	84.23	0.04	1.45	Upgrade
Debt Issued / Paid	-5.1	7.31	-1.14	0	1	Upgrade
Other Financing Activities	-	-	-4.49	24.95	-0.11	Upgrade
Financing Cash Flow	41.97	7.93	78.6	24.99	2.34	Upgrade
Net Cash Flow	-7.97	-37.91	49.15	5.04	-0.91	Upgrade
Free Cash Flow	-49.97	-45.81	-29.3	-19.95	-3.25	Upgrade
Free Cash Flow Margin	-115.91%	-207.00%	-209.74%	-528.98%	-902.78%	Upgrade
Free Cash Flow Per Share	-37.98	-70.14	-255.99	-619.26	-273.14	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).